# Oklahoma State University Oklahoma City

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/oklahoma-state-university-oklahoma-city/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 73.4 |
| Citations | 438,822 |
| City | Oklahoma City |
| Country | US |
| Description | Oklahoma State University Oklahoma City is a research organisation in Oklahoma City, US. OpenAlex records 18,271 works and 438,822 citations for it. 3,862 researchers list it as their most recent affiliation. |
| Homepage | http://www.osuokc.edu/home/ |
| OpenAlex ID | https://openalex.org/I4210131712 |
| Region | Oklahoma |
| Researchers | 3,862 |
| ROR ID | https://ror.org/03y1zyv86 |
| Type | education |
| Works | 18,271 |

## University papers

- [Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer](https://scholariq.org/papers/incorporation-of-bevacizumab-in-the-primary-treatment-of-ovarian-cancer/)
- [Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study](https://scholariq.org/papers/phase-iii-trial-of-carboplatin-and-paclitaxel-compared-with-cisplatin-and/)
- [Inherited Mutations in Women With Ovarian Carcinoma](https://scholariq.org/papers/inherited-mutations-in-women-with-ovarian-carcinoma/)
- [Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer](https://scholariq.org/papers/pembrolizumab-plus-chemotherapy-in-advanced-endometrial-cancer/)
- [Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial](https://scholariq.org/papers/bevacizumab-and-paclitaxel-carboplatin-chemotherapy-and-secondary-cytoreduction/)
- [Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer](https://scholariq.org/papers/final-overall-survival-of-a-randomized-trial-of-bevacizumab-for-primary/)

## University top topics

Showing 8 of 21.

- [Particle physics theoretical and experimental studies](https://scholariq.org/topics/particle-physics-theoretical-and-experimental-studies/)
- [High-Energy Particle Collisions Research](https://scholariq.org/topics/high-energy-particle-collisions-research/)
- [Diverse Educational Innovations Studies](https://scholariq.org/topics/diverse-educational-innovations-studies/)
- [Child and Adolescent Psychosocial and Emotional Development](https://scholariq.org/topics/child-and-adolescent-psychosocial-and-emotional-development/)
- [Particle Detector Development and Performance](https://scholariq.org/topics/particle-detector-development-and-performance/)
- [Corporate Finance and Governance](https://scholariq.org/topics/corporate-finance-and-governance/)
- [Economics of Agriculture and Food Markets](https://scholariq.org/topics/economics-of-agriculture-and-food-markets/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.